SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aceragen, Inc. (ACGN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ACGN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.26
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-7.17
Book Value / Share$0.00
Revenue / Share$1.49
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-56.46 |
$47K |
$-18.23M |
-38778.7% |
| 2014 |
$-63.45 |
$73K |
$-38.64M |
-52934.2% |
| 2015 |
$-57.12 |
$249K |
$-48.56M |
-19500% |
| 2016 |
$-40.97 |
$16.2M |
$-38.39M |
-237% |
| 2017 |
$-56.95 |
$902K |
$-65.98M |
-7315.3% |
| 2018 |
$-38.25 |
$662K |
$-59.88M |
-9045.5% |
| 2019 |
$-50.32 |
$1.45M |
$-56.52M |
-3903% |
| 2020 |
$-56.61 |
$0.00 |
$-112.66M |
- |
| 2021 |
$-9.78 |
$0.00 |
$98.09M |
- |
| 2022 |
$-7.17 |
$4.86M |
$-23.36M |
-480.5% |
